OEA for Targeting Lipid Metabolism in GWI

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The study is a single site, randomized, double-blind, placebo-controlled study with an open label extension to evaluate the effects of Oleoylethanolamine (OEA) on blood lipid and immune biomarkers in participants with Gulf War Illness (GWI).
Epistemonikos ID: 28bfd8f3dc449a4d0f28edb870815c3de0893e6f
First added on: May 10, 2024